Close
Nordic 9Nordic 9

Nextech Invest (investor - Private Equity)

Switzerland nextechinvest.com
See something wrong or missing? Let us know
Offices:Zurich

Nextech Invest is a Swiss private equity investor investing in emerging biotechnology companies worldwide by identifying transformative cancer medicines.

Average round investment:207.27M USD
Average number per year:1.0
Distribution: 2024 (1)2023 (1)
Portfolio companies: Germany TubulisGermany Isotopen Technologien München
Mostly invests in: Germany Germany (2) Biotech (2)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Nextech Invest

Name Criteria
United States Deep Track Capital
73%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Frazier Life Sciences
73%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Catalio Capital Management
73%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United Arab Emirates Chimera Investment
73%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Germany Hitachi Ventures
73%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Germany KfW
72%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Switzerland Endeavour Vision
72%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Patient Square Capital
72%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United Kingdom LGT Lightstone
71%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States Fidelity Investments
71%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 2.9
  • Active last 12 months: Yes
Top